top of page

GPCR News 

Post: Blog2_Post

Exscientia welcomes Richard J. Law, as their new Chief Business Officer

March 2022

"Congratulations to Richard J. Law, our newly named Chief Business Officer. Richard is the architect behind nearly all of Exscientia's partnerships and collaborations across pharma and #biotech⁠ and is an advocate for the role of #AI in drug discovery."

Read more at the source

#DrGPCR #GPCR #IndustryNews

0 views0 comments

Recent Posts

See All

August 2022 "THOUSAND OAKS, Calif. and SAN CARLOS, Calif., Aug. 4, 2022 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and ChemoCentryx, Inc., (NASDAQ: CCXI), a biopharmaceutical company focused on orally admin